All terms in DRUGBANK

Label Id Description
S,S'-(1,4-Phenylene-Bis(1,2-Ethanediyl))Bis-Isothiourea DB02141
Pyridoxamine-5'-Phosphate DB02142
N5-Methylglutamine DB03473
Trypanothione DB03470
6-phenyl-4(R)-(7-phenyl-heptanoylamino)-hexanoic acid DB03471
N1-(1-Dimethylcarbamoyl-2-Phenyl-Ethyl)-2-Oxo-N4-(2-Pyridin-2-Yl-Ethyl)-Succinamide DB02140
Sacubitrilat DB14127 [A metabolite of LCZ696 with neprilysin inhibitory activity.]
Norleucine DB15458 [Norleucine is under investigation in clinical trial NCT00081952 (Amino Acid Therapy for Hot Flashes in Postmenopausal Women).]
Tenofovir DB14126 [Tenofovir is an acyclic nucleotide diester analog of adenosine monophosphate.[A37693] In the most strict sense and due to the fact that it presents a phosphate group bound to the nitrogenous base, it is determined as an actual nucleotide analog.[A37693] The antiviral activities of tenofovir were first reported in 1993 and this agent was commercially available since 2008 in the form of [tenofovir disoproxil] and [tenofovir alafenamide] in order to obtain oral bioavailability.[A18473, A178360]]
Snubh-nm-333 F-18 DB15457 [Snubh-nm-333 F-18 is under investigation in clinical trial NCT02149017 (Phase 1 and Phase 2 Clinical Trials of SNUBH-NM-333(18F)).]
Macelignan DB14129 [Macelignan is an NSAID with antioxidant, free radical scavenging, and neuroprotective activities.]
Nadide DB14128 [A coenzyme composed of ribosylnicotinamide 5'-diphosphate coupled to adenosine 5'-phosphate by pyrophosphate linkage. It is found widely in nature and is involved in numerous enzymatic reactions in which it serves as an electron carrier by being alternately oxidized (NAD+) and reduced (NADH). (Dorland, 27th ed)]
Racementhol DB14123
Dihydroxymethoxychalcone DB14122 [Cardamonin (also known as Dihydroxymethoxychalcone), as shown by the increasing number of publications, has received growing attention from the scientific community due to the expectations toward its benefits to human health. Cardamonin's name comes from the fact that it can be found in cardamom spice.]
Naratuximab emtansine DB15453 [Naratuximab emtansine is under investigation in clinical trial NCT01534715 (IMGN529 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia).]
Vericiguat DB15456 [Vericiguat is under investigation in clinical trial NCT02861534 (A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)).]
Benazeprilat DB14125
Cenersen DB15455 [Cenersen is under investigation in clinical trial NCT02243124 (A Study of Aezea® (Cenersen) in Transfusion Dependent Anemia Associated With Myelodysplastic Syndrome (MDS)).]
Cyclomethicone DB14124
PF-05105679 DB15450 [PF-05105679 is under investigation in clinical trial NCT01393652 (Single Dose, Dose Escalation Healthy Volunteers Study Of PF-05105679).]